Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C8,11 | Lung | Primary cancer | 3,269 | Tumor/Malignant | 53.8% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_C8,12 | Lung | Primary cancer | 3,876 | Tumor/Malignant | 86.5% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_C8,13 | Lung | Primary cancer | 2,335 | Tumor/Malignant | 50.0% | 0.98 | 0.04 |
| NSCLC_38242124__IMC__88_C8,14 | Lung | Primary cancer | 3,753 | Immune | 29.2% | 0.55 | 0.84 |
| NSCLC_38242124__IMC__88_C8,15 | Lung | Primary cancer | 1,455 | Stromal | 59.2% | 0.69 | 0.54 |
| NSCLC_38242124__IMC__88_C8,2 | Lung | Primary cancer | 4,428 | Immune | 43.6% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__88_C8,3 | Lung | Primary cancer | 3,424 | Tumor/Malignant | 51.0% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__88_C8,4 | Lung | Primary cancer | 5,850 | Tumor/Malignant | 61.5% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__88_C8,5 | Lung | Primary cancer | 2,521 | Stromal | 44.9% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__88_C8,9 | Lung | Primary cancer | 3,582 | Tumor/Malignant | 71.3% | 0.97 | 0.10 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C8,11 | Lung | Primary cancer | 3,269 | Tumor/Malignant | 53.9% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__88_C8,12 | Lung | Primary cancer | 3,876 | Tumor/Malignant | 78.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__88_C8,13 | Lung | Primary cancer | 2,335 | Tumor/Malignant | 50.0% | 0.98 | 0.04 |
| NSCLC_38242124__IMC__88_C8,14 | Lung | Primary cancer | 3,753 | Lymphoid | 22.8% | 0.58 | 0.88 |
| NSCLC_38242124__IMC__88_C8,15 | Lung | Primary cancer | 1,455 | Stromal | 39.2% | 0.56 | 0.61 |
| NSCLC_38242124__IMC__88_C8,2 | Lung | Primary cancer | 4,428 | Myeloid | 40.4% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__88_C8,3 | Lung | Primary cancer | 3,424 | Tumor/Malignant | 56.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__88_C8,4 | Lung | Primary cancer | 5,850 | Tumor/Malignant | 65.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__88_C8,5 | Lung | Primary cancer | 2,521 | Stromal | 43.6% | 0.90 | 0.28 |
| NSCLC_38242124__IMC__88_C8,9 | Lung | Primary cancer | 3,582 | Tumor/Malignant | 60.8% | 0.99 | 0.03 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__88_C8,11 | Lung | Primary cancer | 3,269 | Tumor/Malignant cell | 65.7% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__88_C8,12 | Lung | Primary cancer | 3,876 | Tumor/Malignant cell | 86.9% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__88_C8,13 | Lung | Primary cancer | 2,335 | Tumor/Malignant cell | 60.9% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_C8,14 | Lung | Primary cancer | 3,753 | T cell | 25.8% | 0.54 | 0.95 |
| NSCLC_38242124__IMC__88_C8,15 | Lung | Primary cancer | 1,455 | Fibroblast | 43.6% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__88_C8,2 | Lung | Primary cancer | 4,428 | Granulocyte | 43.3% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_C8,3 | Lung | Primary cancer | 3,424 | Tumor/Malignant cell | 62.5% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__88_C8,4 | Lung | Primary cancer | 5,850 | Tumor/Malignant cell | 63.0% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__88_C8,5 | Lung | Primary cancer | 2,521 | Fibroblast | 45.1% | 0.88 | 0.34 |
| NSCLC_38242124__IMC__88_C8,9 | Lung | Primary cancer | 3,582 | Tumor/Malignant cell | 68.7% | 0.97 | 0.09 |